# Post-Market Study of ZENFLEX Pro Stent for Femoropopliteal Artery Lesions

Study · id `cardio:ct-nct07049120` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07049120](<https://clinicaltrials.gov/study/NCT07049120>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07049120

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 153 participants.

## Technical summary

Registry record NCT07049120. Allocation not applicable; no masking; primary purpose prevention. Start 2025-06-30 (anticipated); primary completion 2027-05-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 153 participants (planned count; ClinicalTrials.gov record NCT07049120, source copy `cardio:ctgov-nct07049120-2025-07-03`, retrieved 2026-10-31)
- Planned start: 2025-06-30 (anticipated) (ClinicalTrials.gov record NCT07049120, source copy `cardio:ctgov-nct07049120-2025-07-03`, retrieved 2026-10-31)
- Primary completion: 2027-05-31 (anticipated) (ClinicalTrials.gov record NCT07049120, source copy `cardio:ctgov-nct07049120-2025-07-03`, retrieved 2026-10-31)
- Completion: 2027-10-31 (anticipated) (ClinicalTrials.gov record NCT07049120, source copy `cardio:ctgov-nct07049120-2025-07-03`, retrieved 2026-10-31)
- Countries: Poland (ClinicalTrials.gov record NCT07049120, source copy `cardio:ctgov-nct07049120-2025-07-03`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07049120-2025-07-03`, retrieved 2026-10-31)

## The registry's words

- Brief title: Post-Market Study of ZENFLEX Pro Stent for Femoropopliteal Artery Lesions
- Condition: Peripheral Arterial Disease
- Intervention (Device): ZENFLEX Pro™ Peripheral Drug-eluting Stent System
- Lead sponsor: Zhejiang Zylox Medical Device Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Zhejiang Zylox Medical Device Co., Ltd. (`cardio:org-zhejiang-zylox-medical-device-co-ltd`)

## Provenance

Content hash: 72fc352941c32817367c1ab670ce1cef72f7b489fe3cdcc7180fcbb7c16eba7a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
